Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein - PubMed (original) (raw)
. 2007 May 25;282(21):15597-605.
doi: 10.1074/jbc.M610893200. Epub 2007 Mar 29.
Affiliations
- PMID: 17395592
- DOI: 10.1074/jbc.M610893200
Free article
Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein
Marco Bisaglia et al. J Biol Chem. 2007.
Free article
Abstract
Oxidative stress appears to be directly involved in the pathogenesis of several neurodegenerative disorders, including Alzheimer and Parkinson diseases. Nigral dopaminergic neurons are particularly exposed to oxidative stress because a pathological accumulation of cytosolic dopamine gives rise to various toxic molecules, including free radicals and reactive quinones. These latter species can react with proteins preventing them from exerting their physiological functions. Among the possible targets of quinones, alpha-synuclein is of primary interest because of its direct involvement in dopamine metabolism. Contrary to the neurotoxic processes, neuromelanin synthesis seems to play a protective role by its ability to sequester a variety of potentially damaging substances. In this study, we carried out a kinetic and structural analysis of the early oxidation products of dopamine. Specifically, considering the potential high toxicity of aminochrome for both cells and mitochondria, we focused our attention on its rearrangement to 5,6-dihydroxyindole. After the spectroscopic characterization of the products derived from the oxidation of dopamine, the structural information obtained was used to analyze the reactivity of quinones toward alpha-synuclein. Our results suggest that indole-5,6-quinone, rather than dopamine-o-quinone or aminochrome, is the reactive species. We propose that the observed reactivity could represent a general reaction pathway whenever cysteinyl residues are absent in proteins or if they are sterically protected.
Similar articles
- Protective and toxic roles of dopamine in Parkinson's disease.
Segura-Aguilar J, Paris I, Muñoz P, Ferrari E, Zecca L, Zucca FA. Segura-Aguilar J, et al. J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Epub 2014 Mar 18. J Neurochem. 2014. PMID: 24548101 Review. - Dopamine quinones interact with alpha-synuclein to form unstructured adducts.
Bisaglia M, Tosatto L, Munari F, Tessari I, de Laureto PP, Mammi S, Bubacco L. Bisaglia M, et al. Biochem Biophys Res Commun. 2010 Apr 2;394(2):424-8. doi: 10.1016/j.bbrc.2010.03.044. Epub 2010 Mar 10. Biochem Biophys Res Commun. 2010. PMID: 20226175 - Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
Asanuma M, Miyazaki I, Diaz-Corrales FJ, Miyoshi K, Ogawa N, Murata M. Asanuma M, et al. Neurosci Res. 2008 Jan;60(1):106-13. doi: 10.1016/j.neures.2007.10.002. Epub 2007 Oct 10. Neurosci Res. 2008. PMID: 18022268 - The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease.
Tessari I, Bisaglia M, Valle F, Samorì B, Bergantino E, Mammi S, Bubacco L. Tessari I, et al. J Biol Chem. 2008 Jun 13;283(24):16808-17. doi: 10.1074/jbc.M709014200. Epub 2008 Apr 4. J Biol Chem. 2008. PMID: 18390556 - Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration.
Zhang S, Wang R, Wang G. Zhang S, et al. ACS Chem Neurosci. 2019 Feb 20;10(2):945-953. doi: 10.1021/acschemneuro.8b00454. Epub 2019 Jan 17. ACS Chem Neurosci. 2019. PMID: 30592597 Review.
Cited by
- Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.
Pike AF, Longhena F, Faustini G, van Eik JM, Gombert I, Herrebout MAC, Fayed MMHE, Sandre M, Varanita T, Teunissen CE, Hoozemans JJM, Bellucci A, Veerhuis R, Bubacco L. Pike AF, et al. J Neuroinflammation. 2022 Feb 16;19(1):50. doi: 10.1186/s12974-022-02410-4. J Neuroinflammation. 2022. PMID: 35172843 Free PMC article. - Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats.
Badawi GA, Abd El Fattah MA, Zaki HF, El Sayed MI. Badawi GA, et al. Neurotox Res. 2019 Apr;35(3):635-653. doi: 10.1007/s12640-019-9998-3. Epub 2019 Jan 23. Neurotox Res. 2019. PMID: 30673988 - Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.
Feng LR, Maguire-Zeiss KA. Feng LR, et al. Neurotox Res. 2011 Nov;20(4):387-401. doi: 10.1007/s12640-011-9255-x. Epub 2011 Jul 7. Neurotox Res. 2011. PMID: 21735318 Free PMC article. - Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.
Goldstein DS, Kopin IJ, Sharabi Y. Goldstein DS, et al. Pharmacol Ther. 2014 Dec;144(3):268-82. doi: 10.1016/j.pharmthera.2014.06.006. Epub 2014 Jun 16. Pharmacol Ther. 2014. PMID: 24945828 Free PMC article. Review. - Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions.
Yoo JM, Lin Y, Heo Y, Lee YH. Yoo JM, et al. Front Mol Biosci. 2022 Aug 12;9:959425. doi: 10.3389/fmolb.2022.959425. eCollection 2022. Front Mol Biosci. 2022. PMID: 36032665 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources